BioEden's stem cell banking services effectively provide the vital link to therapy by having a persons own stem cells readily available for whenever they may be needed'
(PRWEB UK) 31 December 2015
Last month BioEden announced a 275% increase in demand for their services, compared to the same month in the previous year. Today the results were announced for December 2015, and as the company anticipated has broken all previous records.
The increase in demand has come predominantly from the UK with their US operation being a close second.
The company put their success down to several factors, one being the ease of obtaining the stem cells (from a naturally shed baby tooth), the new affordable way of banking the cells (Membership can cost from just £5 per month) and the increasing awareness of stem cell therapies and treatments. Earlier this year BioEden announced the successful treatment of a BioEden Member for Type 1 Diabetes. Group CEO Tony Veverka said 'the treatment is still ongoing but based on the feedback from the patient and from the treating hospital the results are looking very exciting indeed. BioEden's stem cell banking services effectively provide the vital link to therapy by having a persons own stem cells readily available for whenever they may be needed'
For more information on BioEden contact sue.wilkinson(at)bioeden(dot)com or visit http://www.bioeden.com.